Clear 23°. Wind Chill: 8°. Wind: SW 13 mph.
Trending: UK approves GSK’s twice-yearly asthma drug
HomeNewsNationalHealth ( Page 96)

Health

Subscribe to the Health News Feed.
SHARE NOW
by

Canada pauses cull of ostrich flock that had cases of avian flu amid U.S. push to save them

By Anna Mehler Paperny TORONTO (Reuters) -A flock of Canadian ostriches set to be culled after two dead birds tested positive for avian flu has been granted a last-minute stay of execution from Canada’s highest court – for now. Canada’s Supreme Court issued an order Wednesday ...
by

Healthcare firm Medline considers filing for US IPO, Bloomberg News reports

(Reuters) -Healthcare company Medline is weighing a public filing for an initial public offering as soon as late October, Bloomberg News reported on Wednesday, citing people familiar with the matter. The IPO could raise about $5 billion and value the company at as much as ...
by

Sexually transmitted disease cases fall, but not syphilis in newborns

NEW YORK (AP) — Sexually transmitted disease rates for U.S. adults fell last year, but syphilis in newborns continued to rise, according to new government data posted Wednesday. The Centers for Disease Control and Prevention provisional data for 2024 showed a third consecutive year of ...
by

Mexico studies more actions to contain screwworm outbreak after case close to US border

By Cassandra Garrison MEXICO CITY (Reuters) -Mexico is evaluating additional actions to deal with an outbreak of the flesh-eating screwworm parasite after a case of an infected animal was confirmed in the state of Nuevo Leon, which borders the United States, President Claudia Sheinbaum said ...
by

From rock bottom to wellness: How 3 people kick-started their health journeys

NEW YORK (AP) — Dominique Debroux, James Keppel and Jenny Watson don’t know each other, but all reached a point in their lives where they needed to make drastic changes to turn around potentially life-threatening conditions. And they wanted — badly — to make ...
by

Activist Engine Capital pushes for changes at Acadia Healthcare

(Reuters) -Activist investor Engine Capital sent a letter to Acadia Healthcare’s board on Wednesday asking the company to explore a potential asset sale and add new directors to its board. Shares of Franklin, Tennessee-based Acadia Healthcare rose 4.5% premarket. Engine Capital, which owns about a 3% ...
https://www.osfhealthcare.org/c/only-at-osf-w
by

China’s Jiangsu Hengrui to grant license for cancer drug to unit of India’s Glenmark

(Reuters) -China’s Jiangsu Hengrui Pharmaceuticals said on Wednesday it has agreed to grant a paid license for its innovative cancer drug trastuzumab rezetecan to the Swiss unit of India’s Glenmark Pharmaceuticals. Under the agreement, Hengrui will receive an upfront payment of $18 million and can ...
by

Harmony Biosciences’ genetic disorder drug fails to meet main goal in late-stage trial

(Reuters) -Harmony Biosciences said on Wednesday its experimental drug for a type of rare genetic disorder failed to meet the main goal in a late-stage trial, sending its shares down 8% before the bell. The company has been studying the drug named ZYN002 in patients ...
by

WHO confirms 11 new Ebola cases in Congo

(Reuters) -Eleven new confirmed cases of Ebola were reported in Democratic Republic of Congo since the World Health Organization’s last update on September 15, showing a decreasing trend of cases in the recent week, the UN health agency said on Wednesday. As of September ...
by

French court orders Sanofi to pay $177 million for anti-competitive behaviour

(Reuters) -A Paris court on Wednesday ordered Sanofi and its Winthrop unit to pay 150.7 million euros ($177.1 million) in damages to France’s national health insurance fund (CNAM) for anti-competitive practices related to its anti-clotting drug Plavix. The ruling from the Paris appeals court stems ...
by

Indian drugmakers Dr Reddy’s, Hetero to sell generic HIV prevention drug for $40 a year

By Rishika Sadam and Jennifer Rigby (Reuters) -Indian drugmakers Dr Reddy’s Laboratories and Hetero Labs said on Wednesday that they will sell generic versions of a new and highly effective HIV prevention drug for roughly $40 per year beginning in 2027. Lenacapavir, developed by Gilead ...
by

Acadia’s rare disease therapy fails in late-stage trial, shares drop

(Reuters) -Acadia Pharmaceuticals said on Wednesday it will not proceed further with the development of its intranasal therapy to treat a rare genetic condition after it failed to meet the main goal in a late-stage trial. The company’s shares were down 13% at $20.51 in ...
First Previous9293949596979899100Next Last